Severe Intellectual Disability
Conditions
Keywords
Whole exome sequencing, Molecular diagnostic, Genetic counselling
Brief summary
Evaluation of diagnostic whole exome sequencing in patients with syndromic or isolated severe intellectual disability without a molecular diagnostic, with suspected autosomal recessive inheritance, allowing accurate genetic counseling in this high risk of recurrence group of diseases
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Clinical diagnosis of syndromic or isolated severe intellectual disability (IQ \<50) without a molecular diagnosis * Recurrence in siblings (multiplex families) suggesting autosomal recessive inheritance (with or without parental consanguinity) or sporadic cases from a consanguineous union * Conventional genetic tests performed (including array-CGH) and MRI/CT-scan available * DNA samples from parents and from both unaffected or affected siblings available, for parental segregation and confirmation of candidate variations identified. * Availability of a signed informed consent * To be affiliated or beneficiary of French social security/healthcare system
Exclusion criteria
* Parents in the exclusion period of another study or as provided by the national register of volunteers * High-probability diagnostic hypothesis for which a molecular test is available at lower cost than exome sequencing
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number of patients with a molecular diagnostic and diagnostic yield | up to 12 months |
Secondary
| Measure | Time frame |
|---|---|
| Cost/diagnostic ratio in comparison with conventional techniques | up to 12 months |
| Reporting time in comparison with conventional techniques | up to 12 months |
Countries
France